Literature DB >> 28929142

Enhanced cellular uptake and tumor penetration of nanoparticles by imprinting the "hidden" part of membrane receptors for targeted drug delivery.

Shan Peng1, Yahua Wang, Na Li, Chong Li.   

Abstract

The widely existing transmembrane helices can serve as a novel type of binding site for recognizing corresponding membrane receptors. Through imprinting the transmembrane domain of certain receptors, here we report the construction of polymeric nanoparticles which can achieve enhanced cellular uptake and permeability in target tissues for tumor-targeted drug delivery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28929142     DOI: 10.1039/c7cc05894b

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

1.  Preparation of magnetic molecularly imprinted polymers based on a deep eutectic solvent as the functional monomer for specific recognition of lysozyme.

Authors:  Kaijia Xu; Yuzhi Wang; Xiaoxiao Wei; Jing Chen; Panli Xu; Yigang Zhou
Journal:  Mikrochim Acta       Date:  2018-01-31       Impact factor: 5.833

2.  Low Dose Curcumin Administered in Hyaluronic Acid-Based Nanocapsules Induces Hypotensive Effect in Hypertensive Rats.

Authors:  Izabela Czyzynska-Cichon; Małgorzata Janik-Hazuka; Joanna Szafraniec-Szczęsny; Krzysztof Jasinski; Władysław P Węglarz; Szczepan Zapotoczny; Stefan Chlopicki
Journal:  Int J Nanomedicine       Date:  2021-02-24

Review 3.  The Evolution of Molecular Recognition: From Antibodies to Molecularly Imprinted Polymers (MIPs) as Artificial Counterpart.

Authors:  Ortensia Ilaria Parisi; Fabrizio Francomano; Marco Dattilo; Francesco Patitucci; Sabrina Prete; Fabio Amone; Francesco Puoci
Journal:  J Funct Biomater       Date:  2022-01-28

Review 4.  Recent progress in drug delivery.

Authors:  Chong Li; Jiancheng Wang; Yiguang Wang; Huile Gao; Gang Wei; Yongzhuo Huang; Haijun Yu; Yong Gan; Yongjun Wang; Lin Mei; Huabing Chen; Haiyan Hu; Zhiping Zhang; Yiguang Jin
Journal:  Acta Pharm Sin B       Date:  2019-08-19       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.